List of Tables
Table 1. Global Antiviral Microbial Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Antiviral Microbial Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Antiviral Microbial Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Antiviral Microbial Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Antiviral Microbial Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Antiviral Microbial Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Antiviral Microbial Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Antiviral Microbial Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Antiviral Microbial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antiviral Microbial Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antiviral Microbial Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Antiviral Microbial Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antiviral Microbial Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Microbial Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antiviral Microbial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Antiviral Microbial Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Antiviral Microbial Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Antiviral Microbial Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Antiviral Microbial Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Antiviral Microbial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Antiviral Microbial Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Antiviral Microbial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Antiviral Microbial Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Antiviral Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Antiviral Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Antiviral Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Antiviral Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Antiviral Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Antiviral Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Antiviral Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Antiviral Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Antiviral Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Antiviral Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Antiviral Microbial Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Antiviral Microbial Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Antiviral Microbial Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Antiviral Microbial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Antiviral Microbial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antiviral Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Antiviral Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Antiviral Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Antiviral Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antiviral Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Antiviral Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Antiviral Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Antiviral Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Antiviral Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Antiviral Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Antiviral Microbial Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Antiviral Microbial Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Antiviral Microbial Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Antiviral Microbial Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Antiviral Microbial Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Antiviral Microbial Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Antiviral Microbial Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Antiviral Microbial Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Antiviral Microbial Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Antiviral Microbial Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Antiviral Microbial Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Antiviral Microbial Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Antiviral Microbial Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Antiviral Microbial Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Antiviral Microbial Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Antiviral Microbial Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Antiviral Microbial Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Antiviral Microbial Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Antiviral Microbial Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Antiviral Microbial Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Seres Therapeutics Company Information
Table 71. Seres Therapeutics Description and Business Overview
Table 72. Seres Therapeutics Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Seres Therapeutics Antiviral Microbial Drugs Product
Table 74. Seres Therapeutics Recent Developments/Updates
Table 75. Assembly Biosciences Company Information
Table 76. Assembly Biosciences Description and Business Overview
Table 77. Assembly Biosciences Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Assembly Biosciences Antiviral Microbial Drugs Product
Table 79. Assembly Biosciences Recent Developments/Updates
Table 80. Synthetic Biologics Company Information
Table 81. Synthetic Biologics Description and Business Overview
Table 82. Synthetic Biologics Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Synthetic Biologics Antiviral Microbial Drugs Product
Table 84. Synthetic Biologics Recent Developments/Updates
Table 85. Interxon Company Information
Table 86. Interxon Description and Business Overview
Table 87. Interxon Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Interxon Antiviral Microbial Drugs Product
Table 89. Interxon Recent Developments/Updates
Table 90. PureTech Company Information
Table 91. PureTech Description and Business Overview
Table 92. PureTech Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. PureTech Antiviral Microbial Drugs Product
Table 94. PureTech Recent Developments/Updates
Table 95. Synlogic Company Information
Table 96. Synlogic Description and Business Overview
Table 97. Synlogic Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Synlogic Antiviral Microbial Drugs Product
Table 99. Synlogic Recent Developments/Updates
Table 100. Enterome BioScience Company Information
Table 101. Enterome BioScience Description and Business Overview
Table 102. Enterome BioScience Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Enterome BioScience Antiviral Microbial Drugs Product
Table 104. Enterome BioScience Recent Developments/Updates
Table 105. 4D Pharma Company Information
Table 106. 4D Pharma Description and Business Overview
Table 107. 4D Pharma Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. 4D Pharma Antiviral Microbial Drugs Product
Table 109. 4D Pharma Recent Developments/Updates
Table 110. Second Genome Company Information
Table 111. Second Genome Description and Business Overview
Table 112. Second Genome Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Second Genome Antiviral Microbial Drugs Product
Table 114. Second Genome Recent Developments/Updates
Table 115. AOBiome Company Information
Table 116. AOBiome Description and Business Overview
Table 117. AOBiome Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. AOBiome Antiviral Microbial Drugs Product
Table 119. AOBiome Recent Developments/Updates
Table 120. Rebiotix Company Information
Table 121. Rebiotix Description and Business Overview
Table 122. Rebiotix Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Rebiotix Antiviral Microbial Drugs Product
Table 124. Rebiotix Recent Developments/Updates
Table 125. Metabiomics Company Information
Table 126. Metabiomics Description and Business Overview
Table 127. Metabiomics Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Metabiomics Antiviral Microbial Drugs Product
Table 129. Metabiomics Recent Developments/Updates
Table 130. Ritter Pharmaceuticals Company Information
Table 131. Ritter Pharmaceuticals Description and Business Overview
Table 132. Ritter Pharmaceuticals Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Ritter Pharmaceuticals Antiviral Microbial Drugs Product
Table 134. Ritter Pharmaceuticals Recent Developments/Updates
Table 135. Symberix Company Information
Table 136. Symberix Description and Business Overview
Table 137. Symberix Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Symberix Antiviral Microbial Drugs Product
Table 139. Symberix Recent Developments/Updates
Table 140. OpenBiome Company Information
Table 141. OpenBiome Description and Business Overview
Table 142. OpenBiome Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. OpenBiome Antiviral Microbial Drugs Product
Table 144. OpenBiome Recent Developments/Updates
Table 145. Azitra Company Information
Table 146. Azitra Description and Business Overview
Table 147. Azitra Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Azitra Antiviral Microbial Drugs Product
Table 149. Azitra Recent Developments/Updates
Table 150. Osel Company Information
Table 151. Osel Description and Business Overview
Table 152. Osel Antiviral Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Osel Antiviral Microbial Drugs Product
Table 154. Osel Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Antiviral Microbial Drugs Distributors List
Table 158. Antiviral Microbial Drugs Customers List
Table 159. Antiviral Microbial Drugs Market Trends
Table 160. Antiviral Microbial Drugs Market Drivers
Table 161. Antiviral Microbial Drugs Market Challenges
Table 162. Antiviral Microbial Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antiviral Microbial Drugs
Figure 2. Global Antiviral Microbial Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antiviral Microbial Drugs Market Share by Type: 2024 & 2031
Figure 4. Oral Dosage Form Product Picture
Figure 5. Enteric Capsules Product Picture
Figure 6. Global Antiviral Microbial Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Antiviral Microbial Drugs Market Share by Application: 2024 & 2031
Figure 8. Gastrointestinal Disorders
Figure 9. Autoimmune Disorders
Figure 10. Diabetes
Figure 11. Cancer
Figure 12. Others
Figure 13. Global Antiviral Microbial Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Antiviral Microbial Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Antiviral Microbial Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Antiviral Microbial Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Antiviral Microbial Drugs Report Years Considered
Figure 18. Antiviral Microbial Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Antiviral Microbial Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Antiviral Microbial Drugs Players: Market Share by Revenue in Antiviral Microbial Drugs in 2024
Figure 21. Antiviral Microbial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Antiviral Microbial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Antiviral Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Antiviral Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Antiviral Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Antiviral Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Antiviral Microbial Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Antiviral Microbial Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Antiviral Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Antiviral Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Antiviral Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Antiviral Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Antiviral Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Antiviral Microbial Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Antiviral Microbial Drugs by Type (2020-2031)
Figure 55. Global Antiviral Microbial Drugs Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Antiviral Microbial Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Antiviral Microbial Drugs by Application (2020-2031)
Figure 58. Global Antiviral Microbial Drugs Price (US$/Unit) by Application (2020-2031)
Figure 59. Antiviral Microbial Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
